EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Australian genome-wide association study confirms higher female risk for adult glioma associated with variants in the region of CCDC26

Karen Alpen iD, Claire M Vajdic, Robert J MacInnis, Roger L Milne, Eng-Siew Koh iD, Elizabeth Hovey, Rosemary Harrup, Fiona Bruinsma, Tuong L Nguyen, Shuai Li iD, David Joseph, Geza Benke und 9 weitere

Neuro-Oncology · 2023

DOI: 10.1093/neuonc/noac279 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology, 2023. Verfasst von Karen Alpen und 20 weiteren Autor:innen. Beteiligte Einrichtung: Centre of Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Austral…. Hauptthemen laut MEDLINE: Glioma, Brain Neoplasms, Glioblastoma. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Priority-driven Collaborative Cancer Research Scheme, Cancer Council Australia, Cancer Council New South Wales.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Glioma accounts for approximately 80% of malignant adult brain cancer and its most common subtype, glioblastoma, has one of the lowest 5-year cancer survivals. Fifty risk-associated variants within 34 glioma genetic risk regions have been found by genome-wide association studies (GWAS) with a sex difference reported for 8q24.21 region. We conducted an Australian GWAS by glioma subtype and sex.

Methods

We analyzed genome-wide data from the Australian Genomics and Clinical Outcomes of Glioma (AGOG) consortium for 7 573 692 single nucleotide polymorphisms (SNPs) for 560 glioma cases and 2237 controls of European ancestry. Cases were classified as glioblastoma, non-glioblastoma, astrocytoma or oligodendroglioma. Logistic regression analysis was used to assess the associations of SNPs with glioma risk by subtype and by sex.

Results

We replicated the previously reported glioma risk associations in the regions of 2q33.3 C2orf80, 2q37.3 D2HGDH, 5p15.33 TERT, 7p11.2 EGFR, 8q24.21 CCDC26, 9p21.3 CDKN2BAS, 11q21 MAML2, 11q23.3 PHLDB1, 15q24.2 ETFA, 16p13.3 RHBDF1, 16p13.3 LMF1, 17p13.1 TP53, 20q13.33 RTEL, and 20q13.33 GMEB2 (P < .05). We also replicated the previously reported sex difference at 8q24.21 CCDC26 (P = .0024) with the association being nominally significant for both sexes (P < .05).

Conclusions

Our study supports a stronger female risk association for the region 8q24.21 CCDC26 and highlights the importance of analyzing glioma GWAS by sex. A better understanding of sex differences could provide biological insight into the cause of glioma with implications for prevention, risk prediction and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaBrain NeoplasmsGlioblastomaFemaleHumansAdultMaleGenome-Wide Association StudyGenetic Predisposition to DiseaseAustraliaPolymorphism, Single NucleotideCase-Control StudiesNerve Tissue ProteinsIntracellular Signaling Peptides and Proteins

Stichwörter der Autor:innen

CCDC26GWASglioblastomagliomasex differences

Substanzen

PHLDB1 protein, humanNerve Tissue ProteinsIntracellular Signaling Peptides and Proteins

Autor:innen und Institutionen

  • Centre of Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia.
  • The Kirby Institute, UNSW Sydney, Sydney, New South Wales 2052, Australia.
  • Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria 3004, Australia.
  • Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.
  • South Western Sydney Clinical School, Faculty of Medicine, University of New South Wales, Liverpool, New South Wales, Australia.
  • Liverpool and Macarthur Cancer Therapy Centres, Liverpool Hospital, Liverpool, New South Wales, Australia.

ORCID-Profile: Karen Alpen, Eng-Siew Koh, Shuai Li, Pierre-Antoine Dugué, John L Hopper, Enes Makalic

Förderung

  • Priority-driven Collaborative Cancer Research Scheme
  • Cancer Council Australia
  • Cancer Council New South Wales
  • National Health and Medical Research Council
  • Australian Commonwealth Government
  • NHMRC Senior Principal Research Fellow
  • NHMRC Senior Research Fellow
  • Victorian Cancer Agency Early Career Research Fellow

Zitieren

APA

Alpen, K., Vajdic, C. M., MacInnis, R. J., Milne, R. L., Koh, E. S., Hovey, E., Harrup, R., Bruinsma, F., Nguyen, T. L., Li, S., Joseph, D., Benke, G., Dugué, P. A., Southey, M. C., Giles, G. G., Rosenthal, M., Drummond, K. J., Nowak, A. K., Hopper, J. L., …, & Makalic, E. (2023). Australian genome-wide association study confirms higher female risk for adult glioma associated with variants in the region of CCDC26. Neuro-Oncology. https://doi.org/10.1093/neuonc/noac279

Vancouver

Alpen K, Vajdic CM, MacInnis RJ, Milne RL, Koh ES, Hovey E, et al. Australian genome-wide association study confirms higher female risk for adult glioma associated with variants in the region of CCDC26. Neuro-Oncology. 2023. doi:10.1093/neuonc/noac279

BibTeX
@article{Alpen2023,
  author = {Alpen, Karen and Vajdic, Claire M and MacInnis, Robert J and Milne, Roger L and Koh, Eng-Siew and Hovey, Elizabeth and Harrup, Rosemary and Bruinsma, Fiona and Nguyen, Tuong L and Li, Shuai and Joseph, David and Benke, Geza and Dugué, Pierre-Antoine and Southey, Melissa C and Giles, Graham G and Rosenthal, Mark and Drummond, Katharine J and Nowak, Anna K and Hopper, John L and Kapuscinski, Miroslaw and Makalic, Enes},
  title = {Australian genome-wide association study confirms higher female risk for adult glioma associated with variants in the region of CCDC26},
  journal = {Neuro-Oncology},
  year = {2023},
  doi = {10.1093/neuonc/noac279}
}
Kostenlos starten →